Sitemap

• Overview
• Management Team
• Board of Directors
• Scientific Advisory Board
• Clinical Advisory Board

• Overview
• Posters & Publications

PMN310 | Amyloid-Beta

• Alzheimer’s Disease

PMN267 | TDP-43

• Amyotrophic Lateral Sclerosis (ALS)
• Frontotemporal Dementia (FTD)
• Limbic-predominant age-related TDP-43 encephalopathy (LATE)

PMN442 | Alpha-Synuclein

• Parkinson’s Disease (PD)
• Multiple System Atrophy (MSA)
• Dementia with Lewy Bodies (DLB)

Vaccines

• PMN311 - AD Vaccine
• PMN440 - A-Syn Vaccine

• Overview
• Financial Results
• SEDAR
• SEC Filings

News & Events

• Overview
• Press Releases
• IR Calendar
• Email Alerts

Company Info

• Overview
• Management Team
• Presentations
• Contacts
• FAQ

Stock Data

• NASDAQ: PMN
• Analyst Coverage

Governance

• Overview
• Board of Directors
• Board Committees
• Governance Documents